DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Dey T, Goyal S, Periasamy K, Madan R.
Is low-dose abiraterone for prostate cancer an attractive strategy for limited resource settings?.
Indian J Med Paediatr Oncol 2022;
43 (01) 40-46
Access:
We do not assume any responsibility for the contents of the web pages of other providers.